Select Page

To empower veterans to live more fulfilled lives by treating the root causes of Traumatic Brain Injuries(TBI), Post-Traumatic Stress Disorder (PTSD) & Depression.

What is the Invictus Project

The Invictus Project is a not-for-profit 501(c)(3) organization that is dedicated to improving the lives of veterans and first responders suffering from post-traumatic stress disorder (PTSD), traumatic brain injuries (TBI) and depression. We created this organization because we were patients first and have seen the impact that these treatments have on the lives those who had lost all hope of recovery.

The Invictus Project takes a diagnostics first approach to treating mental health disorders. Any patient that is treated by us or our partner organization’s first receives a QSPECT brain scan, from our partner Cerescan, as well as a full blood panel to evaluate the metabolic processes of both the body and the brain. Following these diagnostic tests patients are assigned a personalized treatment protocol that is designed to address the underlying causes of their symptoms.

After treatment is completed each patient then receives a second battery of testing to evaluate the effectiveness treatment has had on both their body and their brain.

The goal of this venture is twofold:

  1. To improve the long-term quality of life for patients who have been suffering from PTSD, TBI and depression
  2. To collect the treatment data and demonstrate that these treatment protocols not only create greater long-term patient outcomes but are also more cost effective than the current standard of care.

We strive to give back hope

The Invictus Project employs state-of-the-art procedures to reinforce the treatments currently available to trauma patients. Our mission is to drastically improve the lives of those suffering from TBI, PTSD and Depression.


Recent News

Our Progress

Progress as of 3/4/19

To date we have raised over $22,000 from our generous donors and corporate sponsors. Completed treatment on our first patient and have begun the treatment process for our second patient.

read more